Next Article in Journal
7 Tesla MRI Reveals Brain Structural Abnormalities and Neural Plasticity in RPGR-Related Retinitis Pigmentosa
Previous Article in Journal
Predominant Pneumococcal Serotypes in Isolates Causing Invasive Disease in a Spanish Region: An Examination of Their Association with Clinical Factors, Antimicrobial Resistance, and Vaccination Coverage
Previous Article in Special Issue
Comment on Krysik et al. Clinical Outcomes and Early Postoperative Complications in Boston Type I Keratoprosthesis Implantation: A Retrospective Study. J. Clin. Med. 2024, 13, 6710
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Reply

Reply to Mikhail et al. Comment on “Krysik et al. Clinical Outcomes and Early Postoperative Complications in Boston Type I Keratoprosthesis Implantation: A Retrospective Study. J. Clin. Med. 2024, 13, 6710”

by
Katarzyna Krysik
1,2,
Piotr Miklaszewski
1,
Anna Maria Gadamer
1,
Dominika Janiszewska-Bil
1,3,
Anita Lyssek-Boroń
1,2,
Dariusz Dobrowolski
1,4,5,
Beniamin Oskar Grabarek
3,* and
Edward Wylęgała
4
1
Department of Ophthalmology, St. Barbara Hospital, Trauma Centre, 41-200 Sosnowiec, Poland
2
Department of Ophthalmology, Faculty of Medicine, Academy of Silesia, 40-555 Katowice, Poland
3
Collegium Medicum, WSB University, 41-300 Dabrowa Gornicza, Poland
4
Department of Ophthalmology, District Railway Hospital, 40-760 Katowice, Poland
5
Department of Ophthalmology, Faculty of Medicine, Medical University of Silesia, 40-555 Katowice, Poland
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2025, 14(5), 1614; https://doi.org/10.3390/jcm14051614
Submission received: 9 February 2025 / Accepted: 20 February 2025 / Published: 27 February 2025
(This article belongs to the Special Issue Advancements in Cornea Transplantation)
We appreciate the insightful comments from Mikhail et al. on the results of the postoperative observations in our recent article “Clinical Outcomes and Early Postoperative Complications in Boston Type I Keratoprosthesis Implantation: A Retrospective Study” [1].
Despite careful preoperative patient selection, the most common postoperative complication after BKpro implantation is glaucoma [2,3,4]. Preexisting or secondary to keratoprosthesis implantation glaucoma in eyes with severe ocular surface diseases should be controlled as early as possible in order to maintain good visual potential [4]. But this remains a challenge even when previous procedures are applied to normalize intraocular pressure. Many patients have uncommon anatomical conditions following external valve implantation due to changes in the structure of their conjunctiva and conjunctival fornices.
Our observations of the development of glaucoma after implantation indicate a possible correlation with the formation of fibrous or amorphous membranes behind the implant. The cause may be mechanical due to the reaction to the presence of a foreign body in the anterior chamber, but it can be considered a component of uveitis.
Studies on the membranes’ structure and the expression of proinflammatory cytokines in patients with keratoprosthesis implants could explain the cause of the increased intraocular pressure. The material obtained from patients with keratoprosthesis extrusion is currently minimal and does not enable the drawing of conclusions.
We agree with the recommendation of Dr. Mikhail and colleagues that glaucoma surgery should be performed prior to or concurrently with BKPro implantation in eyes with preexisting glaucoma, in order to slow the progression of optic nerve cupping [5].
However, at present, with the current size of the group, we are not able to demonstrate all the risk factors for glaucoma recurrence or its de novo development in eyes with keratoprosthesis. A significant difficulty is the lack of an effective technique for imaging the anterior chamber and the filtration angle after keratoprosthesis implantation. The assessment of these structures, which is important for assessing the etiology of glaucoma, is exceptionally difficult.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Mikhail, D.; Milad, D.; Harissi-Dagher, M. Comment on Krysik et al. Clinical Outcomes and Early Postoperative Complications in Boston Type I Keratoprosthesis Implantation: A Retrospective Study. J. Clin. Med. 2024, 13, 6710. J. Clin. Med. 2025, 14, 1551. [Google Scholar] [CrossRef]
  2. Tsou, B.C.; Koseoglu, N.D.; Akpek, E.K.; Liu, T.Y.A. Ten-Year Outcome of Boston Type 1 Keratoprosthesis Surgery at a Tertiary Care Center. Cornea 2024, 43, 982–988. [Google Scholar] [CrossRef] [PubMed]
  3. Geoffrion, D.; Hassanaly, S.I.; Marchand, M.; Daoud, R.; Agoumi, Y.; Harissi-Dagher, M. Assessment of the Role and Timing of Glaucoma Surgery in Boston Keratoprosthesis Type 1 Patients. Am. J. Ophthalmol. 2022, 235, 249–257. [Google Scholar] [CrossRef]
  4. Geoffrion, D.; Harissi-Dagher, M. Glaucoma Risk Factors and Outcomes Following Boston Keratoprosthesis Type 1 Surgery. Am. J. Opthalmol. 2021, 226, 56–67. [Google Scholar] [CrossRef] [PubMed]
  5. Krysik, K.; Miklaszewski, P.; Gadamer, A.M.; Janiszewska-Bil, D.; Lyssek-Boroń, A.; Dobrowolski, D.; Grabarek, B.O.; Wylęgała, E. Clinical Outcomes and Early Postoperative Complications in Boston Type I Keratoprosthesis Implantation: A Retrospective Study. J. Clin. Med. 2024, 13, 6710. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Krysik, K.; Miklaszewski, P.; Gadamer, A.M.; Janiszewska-Bil, D.; Lyssek-Boroń, A.; Dobrowolski, D.; Grabarek, B.O.; Wylęgała, E. Reply to Mikhail et al. Comment on “Krysik et al. Clinical Outcomes and Early Postoperative Complications in Boston Type I Keratoprosthesis Implantation: A Retrospective Study. J. Clin. Med. 2024, 13, 6710”. J. Clin. Med. 2025, 14, 1614. https://doi.org/10.3390/jcm14051614

AMA Style

Krysik K, Miklaszewski P, Gadamer AM, Janiszewska-Bil D, Lyssek-Boroń A, Dobrowolski D, Grabarek BO, Wylęgała E. Reply to Mikhail et al. Comment on “Krysik et al. Clinical Outcomes and Early Postoperative Complications in Boston Type I Keratoprosthesis Implantation: A Retrospective Study. J. Clin. Med. 2024, 13, 6710”. Journal of Clinical Medicine. 2025; 14(5):1614. https://doi.org/10.3390/jcm14051614

Chicago/Turabian Style

Krysik, Katarzyna, Piotr Miklaszewski, Anna Maria Gadamer, Dominika Janiszewska-Bil, Anita Lyssek-Boroń, Dariusz Dobrowolski, Beniamin Oskar Grabarek, and Edward Wylęgała. 2025. "Reply to Mikhail et al. Comment on “Krysik et al. Clinical Outcomes and Early Postoperative Complications in Boston Type I Keratoprosthesis Implantation: A Retrospective Study. J. Clin. Med. 2024, 13, 6710”" Journal of Clinical Medicine 14, no. 5: 1614. https://doi.org/10.3390/jcm14051614

APA Style

Krysik, K., Miklaszewski, P., Gadamer, A. M., Janiszewska-Bil, D., Lyssek-Boroń, A., Dobrowolski, D., Grabarek, B. O., & Wylęgała, E. (2025). Reply to Mikhail et al. Comment on “Krysik et al. Clinical Outcomes and Early Postoperative Complications in Boston Type I Keratoprosthesis Implantation: A Retrospective Study. J. Clin. Med. 2024, 13, 6710”. Journal of Clinical Medicine, 14(5), 1614. https://doi.org/10.3390/jcm14051614

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop